Sequoia is a venture capital focused on energy, financial, enterprise, healthcare, internet, and mobile startups. The firm helps a small number of daring founders build legendary companies. It spurs them to push the boundaries of what’s possible. The firm seeks to invest in all sectors with a focus on energy, financials and financial services, healthcare and healthcare services, Internet, mobile, outsourcing, and technology.

Sequoia Capital

Shasta Ventures invests in startups in sectors. Their program consists of a proven methodology and a set of comprehensive playbooks that dive deep into the obstacles and challenges of early-stage startups. There is no one-size-fits-all when it comes to early-stage, so this agile program allows founders to tap into the resources they need when they need them.

Shasta Ventures

Y Combinator is a startup accelerator that invests in a large number of startups twice a year. It created a new model for funding startups. Twice a year, the company invests a small amount of money ($150k) in a large number of startups. The startup accelerator works intensively with the companies for three months, to get them into the best possible shape and refine their pitch to investors. Each cycle culminates in Demo Day when the startups present their companies to a carefully selected, invite-only audience.

Y Combinator

Initialized Capital is an early-stage venture capital firm focused on the seed. Initialized has 6 investing partners and over $3.2B under management over five core funds since its founding in 2012. The firm's startups have created in aggregate over $200B in market value so far.

Initialized Capital

Dorm Room Fund is the strongest community of entrepreneurial students in the nation. Built by students and powered by First Round, we provide founders with a strong network of investors, world-class mentors, and a $20,000 check.

Dorm Room Fund

Liquid2 Ventures provides technology startups with seed-stage investments and is based in San Francisco, California. The firm was founded in 2015 by Joe Montana, Mike Miller, and Michael Ma.

Liquid 2 Ventures

Fifty Years is a venture capital firm that backs founders using technology to solve the world's biggest problems.  Entrepreneur-run and based in San Francisco, Fifty Years invests in companies that inspire. Specifically, they fund companies that, if successful, will be both massively profitable and make a serious dent in achieving one or more of the Sustainable Development Goals.

Fifty Years

Founded in 2015, CSC Upshot Ventures is an early-stage venture fund focusing on providing seed capital to technology companies at scale. The firm seeks to invest in companies operating in the enterprise, artificial intelligence, healthcare, Fintech, and the marketplace. In close partnership with AngelList, CSC Upshot Ventures built a new model of venture investing based on the needs of founders, investors, and startup communities.

CSC Upshot

General Catalyst is a venture capital firm that provides early-stage and growth equity investments. The company provides ongoing momentum that accelerates ideas, careers, and companies toward standout success.

General Catalyst

Tribe Capital is a top-quartile venture capital firm focused on capturing a perpetual edge in venture and crypto using data science. The team is made up of investors, engineers and scientists who use artificial intelligence (“AI”) and data science to model venture-backed private companies. Beyond investment capital, Tribe deploys these AI tools to separate signal from noise, helping our companies understand their businesses better.  Our data-informed strategy includes an underwriting infrastructure and a quantitative analysis tool called the “Magic 8-ball.” We leverage these tools to provide deep insight on factors driving growth and how to accelerate sustainable growth, honed through years of developing similar products at major tech and finance players like Lyft, Yahoo, Facebook, and Bridgewater Associates.   Our team uses these tools to measure quantitative product-market fit, so we can more effectively assess and accelerate what Tribe refers to as “N-of-1” companies - companies with the potential to be 10-100x growth opportunities, while minimizing loss ratio by a large degree.  Tribe Capital has $1.6 billion in assets under management and has made notable investments in Apollo.io, Carta, Docker, Kraken, Instabase, Relativity Space, and Shiprocket.

Tribe Capital

Human Capital is a venture firm for builders. We believe ambitious builders turn great ideas into great companies. We invest in founders, teams, and startups that share this mindset. In the last 6 years, that mantra has led us to invest in 15 companies before they became unicorns, including Snowflake, Anduril, Livongo, and Brex (where we wrote the first check). We have over $1.3B in total capital committed and we've built a community of over 5,000 incredible, driven, ambitious builders.

Human Capital

‍Greenoaks makes concentrated, long-term investments in generational teams building enduring companies. The firm invests behind exceptional leaders early in their journeys, building partnerships that endure for decades.

Greenoaks

Athelas

Athelas develops technology to monitor chronically ill patients in their homes. The company has deployed an FDA-cleared blood diagnostic device along with an array of other sensors to manage Blood Pressure, Weight, Glucose, and Medication Adherence.

<div>Athelas is an end-to-end remote patient monitoring (RPM) platform that covers a wide range of chronic conditions such as hypertension, cardiac disorders, kidney failure, and diabetes. The company&rsquo;s flagship product is an FDA-approved blood testing device, Athelas One, which takes blood samples through a finger prick and uses them to track an individual&rsquo;s white blood cell count. The device was developed for immunocompromised individuals such as patients receiving treatment for cancer and individuals that are prescribed clozapine for schizophrenia. The company has since expanded its product portfolio to five different patient vitals monitoring devices including a blood pressure cuff, glucometer, weight scale, and smart medication storage system. Additionally, the company has an accompanying patient app for weight management and an app for doctors to access information on each of their patients.&nbsp;</div>

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

Health startup Athelas its $1.5 billion valuation after pandemic boom

<div>
 
 Athelas is an end-to-end remote patient monitoring (RPM) platform that covers a wide range of chronic conditions such as hypertension, cardiac disorders, kidney failure, and diabetes. The company&rsquo;s flagship product is an FDA-approved blood testing device, Athelas One, which takes blood samples through a finger prick and uses them to track an individual&rsquo;s white blood cell count. The device was developed for immunocompromised individuals such as patients receiving treatment for cancer and individuals that are prescribed clozapine for schizophrenia. The company has since expanded its product portfolio to five different patient vitals monitoring devices including a blood pressure cuff, glucometer, weight scale, and smart medication storage system. Additionally, the company has an accompanying patient app for weight management and an app for doctors to access information on each of their patients.&nbsp; 
 
 
 The company operates a B2B2C model and the devices are available to consumers through healthcare providers. It charges a subscription for each device when it is sent home with a patient. Althelas&rsquo; own network of nurses review data collected from its devices and notifies a patient&rsquo;s caregiver if any abnormalities are observed. The collected health data also integrates with major electronic health records systems. In 2021, the company had 40,000 monthly users, 10x higher than the previous year.
 
 
 As of January 2022, the company raised USD 132 million in two consecutive funding rounds led by General Catalyst and Tribe Capital, which valued the company at USD 1.5 billion and propelled it to unicorn status. The funds are earmarked to further develop its RPM and chronic care management programs for hospitals and health systems.&nbsp;
 
</div>

<div>
 
 Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
 
 
 In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
 
 
 
</div>

Nice Healthcare

Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications.Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.

Amicomed

Winston is a men’s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients.The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.

Winston

<div>
 
 Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
 
 
 The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care, wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
 
 
 Key Customers and partnerships
 
 
 Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
 
 
 Fundings and financials
 
 
 As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
 
 
 In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
 an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
 
 Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
 <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
 acquired by financial services company Sun Life Financial
 </a>
 for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
 
 
 
</div>

Dialogue

Grin offers telemedicine and remote monitoring services for orthodontic needs such as braces and teeth straightening. Patients can conduct self-scans (using a Grin device made available to patients in collaboration with 3M) which can be connected to their smartphones and share the feed with orthodontists to access dental solutions. The company plans to go to a subscription-based model after the pandemic. The app also encourages patients to have a 40-second check monthly and share the scan with a dentist in order to allow patients to regularly maintain their dental hygiene.Grin is the only Telehealth disruptor covered on the hub that provides virtual orthopaedic consultations.Funding and financialsIn April 2021, the New York-based teledental platform concluded a seed funding of USD 14 million, and the funds will be allocated to develop additional functionalities by building out its technology. The proceeds will also be used to scale up its team, expand its geographic footprint, and add doctors to the company’s orthodontic partner network.

Grin

Real-time collection of patients’ health-related data using any remote patient monitoring device combined with general telemedicine services to reduce readmission rates. 


A platform that facilitates the transmission of patient data to different locations for further evaluation and interpretation by medical specialists. 


A digital platform that offers specialty care services to address the specific needs of a patient or demographic, including consultations where patients are generally reluctant to meet practitioners face-to-face.

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app. 

Companies developing B2B software solutions for patient engagement, care navigation, practice management, and electronic health records integration to facilitate telehealth services for healthcare providers. 

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

Athelas

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless